PACS Group (NYSE:PACS) Earns Outperform Rating from Analysts at Oppenheimer

Oppenheimer started coverage on shares of PACS Group (NYSE:PACS) in a report released on Monday, Marketbeat reports. The firm issued an outperform rating and a $31.00 target price on the stock.

Several other research analysts have also recently issued reports on PACS. Truist Financial assumed coverage on PACS Group in a research note on Monday. They issued a buy rating and a $32.00 price target for the company. Royal Bank of Canada began coverage on shares of PACS Group in a report on Monday. They set an outperform rating and a $30.00 target price for the company. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has an average rating of Buy and a consensus target price of $30.50.

PACS Group Stock Performance

Shares of NYSE:PACS opened at $24.67 on Monday. PACS Group has a 52 week low of $22.61 and a 52 week high of $25.72.

Insider Activity

In other news, CEO Jason Hulse Murray sold 1,607,142 shares of the firm’s stock in a transaction on Monday, April 15th. The stock was sold at an average price of $21.00, for a total value of $33,749,982.00. Following the completion of the sale, the chief executive officer now owns 62,754,551 shares of the company’s stock, valued at $1,317,845,571. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.